accounton the drug had fewer heart complications, though the numbers were small. Roche, based in Basel, Switzerland, and Eli Lilly & Co. of Indianapolis have similar drugs in development, which analysts estimate may generate as much as $15 billion in peak...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Abbott Cholesterol Combination Fails to Protect Heart in Study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account